Catalyst Wire Dossier Catalyst Wire Dossier

R-ACVBP regimen with pegfilgrastim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R-ACVBP regimen with pegfilgrastim, covering 2018-08-23 to 2018-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma [Phase 2]

See pricing